Oren Gilad Aprea Therapeutics, Inc. (APRE) insider trading activity

Oren Gilad is President/CEO of Aprea Therapeutics, Inc.. Currently has a direct ownership of 333,395 shares of APRE, which is worth approximately $973,513. The most recent transaction as insider was on Oct 23, 2024, when has been sold 500 shares (Common Stock) at a price of $3.92 per share, resulting in proceeds of $1,960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 333K

0.57% 3M change

3.29% 12M change

Total Value Held $973,513

Oren Gilad Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 23 2024	BUY Open market or private purchase	$1,960 $3.92 p/Share	500 Added 0.15%	333,395 Common Stock
Oct 15 2024	BUY Open market or private purchase	$725 $2.9 p/Share	250 Added 0.08%	332,895 Common Stock
Oct 14 2024	BUY Open market or private purchase	$2,590 $2.59 p/Share	1,000 Added 0.3%	332,645 Common Stock
Oct 10 2024	BUY Open market or private purchase	$381 $2.54 p/Share	150 Added 0.05%	331,645 Common Stock
Mar 28 2024	BUY Grant, award, or other acquisition	-	6,725 Added 1.99%	331,495 Common Stock
Mar 13 2024	BUY Open market or private purchase	$14,580 $7.29 p/Share	2,000 Added 0.61%	324,770 Common Stock
Mar 09 2023	BUY Grant, award, or other acquisition	-	4,000 Added 1.22%	322,770 Common Stock
Aug 23 2022	BUY Conversion of derivative security	-	6,045,100 Added 48.67%	6,375,414 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	101,300 Added 23.47%	330,314 Common Stock

Oren Gilad

President/CEO

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if

Value

Insider Trading

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aprea Therapeutics, Inc.

Track Activities on APRE

Account